[1]
T. Kiss, G. Katona, and R. Ambrus, “Crystallization and physicochemical investigation of melevodopa hydrochloride, a commercially available antiparkinsonian active substance”, Acta Pharm Hung, vol. 91, no. 2, pp. 45-52, Nov. 2021.